In vivo and in vitro allergy diagnostics: It's time to reappraise the costs

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 3, 2007, Pages 391-395

  Borghesan, Franco ^a   Bernardi, Daniela ^a   Plebani, Mario ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Allergen specific immunotherapy; Cost comparison; IgE determination; Recombinant allergen; Skin prick tests

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; CORTICOSTEROID; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY;

ADOLESCENT; ADULT; ALLERGY; ASTHMA; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FEMALE; HAY FEVER; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RHINITIS; SCHOOL CHILD; SKIN TEST;

ADOLESCENT; ADULT; ALLERGENS; AUTOMATION; CHILD; FEMALE; HUMANS; HYPERSENSITIVITY; ITALY; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; SKIN TESTS;

EID: 33947594511     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2007.077     Document Type: Conference Paper

References (27)

1. Dolen WK. It is not time to stop skin testing, but... J Allergy Clin Immunol 2000;105:1074-6.
2. Plebani M. Clinical value and measurement of specific IgE [review]. Clin Biochem 2003;36:453-69.
3. Plebani M, Borghesan F, Faggian D. Clinical efficiency of in vitro and in vivo tests for allergic diseases. Ann Allergy Asthma Immunol 1995;74:23-8.
4. Ricci G, Capelli M, Miniero R, Menna G, Zannarini L, Dillon P, et al. A comparison of different allergometric tests, skin prick test, Pharmacia UniCAP and ADVIA Centaur, for diagnosis of allergic diseases in children. Allergy 2003;58:38-45.
5. Prates S, Morais-Almeida M, Matos V, Loureiro V, Rosado-Pinto J. In vitro methods for specific IgE detection in cow's milk allergy. Allergol Immunopathol 2006;34:27-31.
6. Nolte H, DuBuske LM. Performance characteristics of a new automated enzyme immunoassay for the measurement of allergen-specific IgE. Summary of the probability outcomes comparing results of allergen skin testing to results obtained with the HYTEC system and CAP system. Ann Allergy Asthma Immunol 1997;79:27-34.
7. Hill DJ, Hosking CS, Reyes-Benito LV. Reducing the need for food allergen challenges in young children: a comparison of in vitro with in vivo tests. Clin Exp Allergy 2001;31:1031-5.
8. Keskin O, Tuncer A, Adalioglu G, Sekerel BE, Sackesen C, Kalyci O. Evaluation of the utility of atopy patch testing, skin prick testing, and total and specific IgE assays in the diagnosis of cow's milk allergy. Ann Allergy Immunol 2005;94:553-60.
9. Valenta R, Lidholm J, Niederberger V, Hayek B, Kraft D, Gronlund H. The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). Clin Exp Allergy 1999;29:896-904.
10. Mothes N, Valenta R, Spitzauer S. Rekombinante Allergene für die Diagnose der Typ I-Allergie. J Lab Med 2005;29:263-71;
11. Mothes N, Valenta R, Spitzauer S. Allergy testing: the role of recombinant allergens. Clin Chem Lab Med 2006;44:125-32.
12. Crameri R. Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy. Immunol Allergy Clin North Am 2006;26:179-89.
13. Bousquet J, Lockey R, Malling HJ, Alvarez-Cuesta E, Canonica GW, Chapman MD, et al. Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American Academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1998;81:401-5.
14. Finegold I. What's in a name? Vaccine versus extracts. Ann Allergy Asthma Immunol 1998;81:377.
15. Radauer C, Breiteneder H. Pollen allergens are restricted to few protein families and show distinct patterns of species distribution. J Allergy Clin Immunol 2006;117:141-7.
16. Weber RW. Cross-reactivity of pollen allergens. Curr Allergy Asthma Rep 2004;4:401-8.
17. Durham SR, Walker SM, Varga EM, Jacobson MR, O'Brien F, Noble W, et al. Long-term efficacy of grasspollen immunotherapy. N Engl J Med 1999;341:468-75.
18. Eng PA, Reinhold M, Gnehm HP. Long-term efficacy of preseasonal grass pollen immunotherapy in children. Allergy 2002;57:306-12.
19. Moller C, Dreborg S, Ferdousi HA, Halken S, Jacobsen L, Koivikko A, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT study). J Allergy Clin Immunol 2002;109:251-6.
20. Valovirta E. Capacity of specific immunotherapy in prevention of allergic asthma in children: the preventive allergy treatment study (PAT). J Invest Allergol Clin Immunol 1997;7:369.
21. Società Italiana di Allergologia e Immunologia Clinica. Memorandum sulla diagnostica delle allergopatie. Giorn It Allergol Immunol Clin 1992;351:2-20.
22. Williams PB, Dolen WK, Koepke JW, Selner JC. Comparison of skin testing and three in vitro assays for specific IgE in the clinical evaluation of immediate hypersensitivity. Am Allergy 1992;68:35-45.
23. Lockey R, Lichtestein L, Bloch K, Kaliner M, Zweiman B, Rochelesky G. Position statement. The use of in vitro tests for IgE antibody in the specific diagnosis of the IgE-mediated disorders and in the formulation of allergen immunotherapy. J Allergy Clin Immunol 1992;90:263-7.
24. Pittner G, Vrtala S, Thomas WR, Weghofer M, Kundi M, Horak F, et al. Component-resolved diagnosis of house-dust mite allergy with purified natural and recombinant mite allergens. Clin Exp Allergy 2004;34:597-603.
25. Rossi RE, Monasterolo G. Evaluation of recombinant and native timothy pollen (rPhI p1,2,5,6,7,11,12 and nPhI p4)-specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients. Int Arch Allergy Immunol 2004;135:44-53.
26. Foetisch K, Westphal S, Lauer I, Retzek M, Altmann F, Kolarich D, et al. Biological activity of IgE specific for cross-reactive carbohydrate determinants. J Allergy Clin Immunol 2003;111:889-96.
27. Bousquet J, Becker WM, Hejjaoui A, Chanal I, Lebel B, Dhivert H, et al. Differences in clinical and immunologic reactivity of patients allergic to grass pollens and to multiple-pollen species. II. Efficacy of a double-blind, placebo-controlled, specific immunotherapy with standardized extracts. J Allergy Clin Immunol 1991;88:43-53.